cyclophilin
cypa
discov
origin
receptor
immunosuppress
drug
cyclosporin
csa
molecul
exhibit
multipl
biolog
function
format
complex
cypa
csa
cyclic
peptid
isol
fungu
tolypocladium
inflatum
allow
cypa
interact
calcineurin
reduc
product
interferon
exert
immunosuppress
effect
cypa
one
known
human
cyclophilin
catalyz
isomer
peptid
bond
contain
prolin
via
peptidyl
prolyl
isomeras
ppias
activ
recent
report
cypa
interact
part
hepat
c
viru
polymeras
nucleocapsid
protein
sar
coronaviru
capsid
ca
protein
human
immunodefici
viru
type
multipl
function
make
cypa
attract
target
drug
develop
addit
csa
natur
product
sanglifehrin
sever
peptid
analog
report
activ
inhibitor
cypa
recent
decreas
infect
disrupt
interact
cypa
ca
sever
small
molecul
develop
howev
new
drug
infect
exhibit
mechan
action
yet
approv
nevertheless
sever
publish
report
structur
inform
regard
bind
mode
cypa
ca
fragment
csa
small
peptid
avail
inform
suggest
potenti
applic
silico
inhibitor
screen
design
elucid
potenti
inhibitor
screen
small
databas
smallmolecularweight
compound
total
compound
select
accord
dock
score
togeth
two
commerci
posit
control
compound
select
compound
test
use
biolog
assay
final
two
compound
identifi
potent
antihiv
candid
display
accept
cellular
toxic
structur
lowmolecularweight
compound
chemic
structur
data
sd
file
format
obtain
chemgenesi
http
wwwallchemycom
suppli
compound
sampl
file
sd
file
convert
molecular
oper
environ
moe
chemic
comput
group
montreal
canada
databas
format
energi
optim
molecul
perform
forcefield
use
moe
softwar
packag
descriptor
molecular
weight
lipviol
lipdruglik
diamet
calcul
type
field
databas
confirm
basic
properti
compound
databas
resolut
crystallograph
data
cypa
complex
dipeptid
alanineprolin
ap
pdb
entri
obtain
brookhaven
protein
data
bank
http
wwwpdborgpdb
cocrystal
structur
use
preliminari
studi
determin
whether
dock
paramet
use
appropri
structur
cypa
within
structur
use
receptor
screen
allchemi
databas
present
studi
moe
dock
program
use
perform
screen
procedur
modul
moe
use
assign
ioniz
state
posit
hydrogen
atom
receptor
molecul
subsequ
ad
partial
charg
forcefield
fix
backbon
atom
energi
minim
receptor
perform
activ
site
cover
entir
area
two
pocket
cypa
molecul
found
use
sitefind
modul
moe
dummi
atom
hydrophob
hydrophil
properti
place
two
pocket
defin
site
dock
ap
back
receptor
selfdock
redock
screen
prepar
databas
simplic
flexibl
ligand
atom
allow
contrast
receptor
atom
dock
studi
use
five
stage
moe
dock
modul
determin
potenti
dock
pose
ligand
dock
use
gener
conform
singl
conform
appli
collect
prefer
torsion
angl
rotat
bond
systemat
search
conduct
cover
combin
angl
grid
result
fewer
conform
otherwis
stochast
sampl
conform
conduct
collect
pose
gener
pool
ligand
conform
use
triangl
matcher
method
align
ligand
triplet
atom
triplet
alpha
sphere
rel
systemat
way
pose
gener
placement
methodolog
rescor
use
london
dg
score
function
low
score
assign
good
pose
top
pose
kept
pose
refin
use
explicit
molecular
mechan
forcefield
method
time
forcefield
set
pose
result
refin
stage
rescor
use
london
dg
score
function
top
pose
compound
retain
manual
examin
final
candid
use
examin
select
accord
best
dock
score
compound
compound
obtain
chemgenesi
posit
control
compound
purchas
namiki
shoji
http
wwwnamikiscojp
biolog
assay
perform
determin
whether
compound
exert
inhibitori
effect
singl
replic
cycl
briefli
cell
cell
dish
transfect
envelop
glycoproteindefici
provir
construct
carri
luciferas
report
gene
pnllucer
togeth
vesicular
stomat
viru
g
protein
vsvg
express
plasmid
phitg
use
fugen
hd
transfect
reagent
roch
basel
switzerland
gener
vsvgpseudotyp
eighteen
hour
later
transfect
cell
trypsin
split
subcultur
plate
presenc
indic
concentr
test
compound
h
incub
cell
cultur
supernat
use
infect
subconflu
cell
treat
correspond
compound
twentyfour
hour
infect
luciferas
activ
infect
cell
measur
use
steadi
glo
luciferas
assay
kit
promega
madison
wi
micropl
luminomet
berthold
bad
wildbad
germani
accord
manufactur
protocol
inhibitori
effect
compound
viral
replic
evalu
reduct
luciferas
activ
infect
cell
addit
cell
toxic
test
perform
use
cell
prolifer
assay
system
roch
accord
manufactur
protocol
briefli
subconflu
cell
treat
indic
concentr
compound
h
reagent
ad
cell
cultur
incub
absorb
sampl
nm
approxim
approxim
h
cell
h
absorb
sampl
measur
use
micropl
reader
multiskan
fc
thermo
scientif
rockford
il
cytotox
compound
evalu
reduct
absorb
cell
obtain
aid
research
refer
reagent
program
divis
aid
niaid
nih
hongkui
deng
dan
r
littman
interact
mode
best
pose
select
ligand
assess
use
ligand
interact
modul
moe
distanc
import
residu
ligand
measur
subsequ
best
dock
pose
activ
compound
complex
cypa
analyz
use
ife
creat
dr
hooman
shadnia
carleton
univers
retriev
svl
exchang
servic
mention
report
shadnia
other
ife
partit
nativ
forcefield
potenti
deriv
net
interact
forc
use
decompos
interact
forc
three
dimens
analyz
perresidu
interact
list
posit
neg
interact
energi
valu
ligand
neighbor
receptor
residu
within
defin
distanc
rang
calcul
neg
valu
indic
favor
interact
wherea
posit
valu
indic
unfavor
interact
candid
ligand
receptor
residu
orient
less
analyz
ensur
valid
dock
procedur
dock
paramet
screen
perform
test
use
cocrystallograph
data
pdb
identifi
cypa
ap
fig
ap
isol
complex
redock
receptor
cypa
use
moe
softwar
packag
best
dock
pose
emerg
dock
differ
origin
conform
root
mean
squar
deviat
rsmd
therefor
select
pose
display
lowest
dock
score
best
pose
figur
show
comparison
xray
crystal
structur
color
red
ap
best
dock
pose
color
blue
select
commerci
avail
databas
chemgenesi
http
wwwallchemycom
contain
lowmolecularweight
compound
sourc
databas
druglik
compound
calcul
quasardescriptor
modul
moe
compound
obey
druglik
number
violat
lipinski
rule
five
less
two
although
less
druglik
compound
usual
remov
target
databas
dock
small
number
compound
databas
druglik
less
druglik
compound
test
calcul
molecular
weight
compound
vari
da
compound
molecular
weight
less
da
accord
pocket
size
cypa
diamet
compound
vari
consid
suitabl
compound
reject
perform
dock
studi
accord
cocryst
data
cypaap
cypa
adopt
eightstrand
antiparallel
beta
barrel
structur
fig
ap
buri
deepli
one
caviti
surfac
cypa
fig
caviti
also
csa
hiv
ca
fragment
substrat
bind
import
residu
caviti
identifi
sitedirect
mutagenesi
caviti
also
call
site
pocket
accord
csa
bind
mode
previou
report
saddlelik
region
anoth
hydrophob
pocket
call
site
b
pocket
addit
site
b
also
empti
space
refer
site
c
fig
although
cocrystallograph
data
cypaca
fragment
indic
site
direct
dock
site
site
b
c
could
consid
auxiliari
caviti
compound
possess
import
elong
function
group
therefor
use
sitefind
modul
moe
defin
larger
dock
region
contain
among
site
b
c
dock
compound
target
databas
cypa
accord
predict
fit
score
express
lowest
bind
energi
certain
pose
select
compound
shown
fig
two
previous
report
activ
compound
control
observ
two
bind
mode
molecul
cover
site
site
b
molecul
place
site
b
site
c
site
fig
compound
list
fig
bound
style
mode
fig
compound
style
mode
fig
lowest
score
pose
site
confirm
respons
ppias
activ
cypa
serv
bind
site
ca
fragment
hiv
csa
thu
sever
group
made
effort
locat
compound
fill
pocket
much
possibl
screen
andor
molecular
design
experi
therefor
molecul
interact
cypa
mode
like
investig
howev
inhibitori
activ
candid
limit
micromolar
level
find
potent
inhibitor
candid
novel
skeleton
kept
mode
mode
compound
biolog
evalu
biolog
assay
perform
determin
whether
compound
posit
control
exert
inhibitori
effect
viral
replic
induc
cellular
toxic
cell
employ
virusproduc
cell
wherea
cell
line
report
cell
line
express
receptor
use
viral
target
cell
assay
system
evalu
inhibitori
effect
test
compound
singl
replic
cycl
result
demonstr
test
compound
either
exert
notic
inhibitori
effect
replic
exhibit
strong
cytotox
higher
concentr
tabl
moreov
although
compound
exert
inhibitori
effect
viral
replic
display
low
solubl
tabl
therefor
evalu
compound
contrast
two
compound
well
two
posit
control
compound
exert
potent
inhibitori
effect
replic
exhibit
low
cytotox
effect
concentr
inhibit
viral
growth
fig
compar
control
compound
hit
compound
exhibit
stronger
inhibitori
activ
dock
pose
compound
differ
best
dock
pose
util
mode
bind
fig
wherea
util
mode
bind
fig
interact
first
assess
use
ligand
interact
modul
moe
analys
provid
direct
schemat
view
interact
cypa
shown
fig
c
respect
compound
insert
site
site
b
figur
b
illustr
dimension
interact
map
dock
pose
respect
cypa
presenc
appear
respons
bind
site
cypa
oxygen
atom
sulfonamid
group
interact
nitrogen
atom
posit
cypa
within
distanc
aromat
ring
nitrobenzen
interact
two
edgetoend
tshape
hydrogenaromat
ring
interact
aromat
h
aromat
aromat
ring
form
stack
network
import
pocketform
residu
highli
conserv
cypa
isol
interact
meaning
inhibitor
design
anoth
key
interact
reveal
interact
map
hydrophob
interact
triazol
group
arenec
interact
benzen
detect
mention
critic
residu
ligand
bind
interact
partli
explain
activ
geometrybas
interact
fingerprint
provid
loos
approxim
insight
fit
two
activ
compound
receptor
site
howev
difficult
determin
detail
intermolecular
energi
particularli
term
hydrophob
interact
therefor
perform
addit
postdock
analys
interact
bind
site
residu
activ
compound
scrutin
use
ife
creat
dr
hooman
shadnia
carleton
univers
http
wwwshadniacomhifeindexhtm
retriev
svl
exchang
servic
program
differenti
favor
interact
unfavor
one
forc
vector
energi
valu
neg
sign
indic
stabl
interact
wherea
posit
sign
indic
unstabl
repuls
interact
result
residu
near
ligand
atom
less
distanc
present
fig
addit
import
residu
mention
see
also
respons
bind
fig
carbon
backbon
approxim
carbonyl
oxygen
separ
fig
dispers
forc
electronpoor
environ
backbon
carbon
electronrich
environ
carbonyl
oxygen
result
good
bind
effect
negativesign
interact
energi
valu
indic
favor
residu
ligand
bind
could
detect
multipl
residu
cypa
includ
aforement
residu
addit
favor
residu
bind
list
fig
convers
strong
signal
positivesign
peak
could
detect
suggest
unfavor
residu
bind
assess
atom
distanc
found
methyl
hydrogen
atom
side
chain
aromat
hydrogen
atom
approxim
apart
fig
conclud
two
hydrogen
atom
clash
howev
underlin
dock
pose
obtain
rigid
receptor
dock
procedur
therefor
model
explain
inducedfit
phenomena
assum
due
strong
repuls
detect
receptor
residu
shift
appropri
orient
real
system
compound
similar
skeleton
howev
exhibit
differ
dock
mode
molecul
target
combin
region
two
mode
assum
activ
type
combin
molecul
investig
use
insilicobas
method
present
work
involv
discoveri
inhibitor
target
cypa
via
silico
biolog
screen
method
twentynin
compound
select
databas
togeth
control
compound
examin
antivir
activ
two
compound
exhibit
compar
good
effect
biolog
assay
particular
compound
exhibit
activ
rel
low
cytotox
effect
concentr
inhibit
viral
growth
experiment
result
may
use
lead
compound
novel
type
antihiv
inhibitor
although
biochem
experi
confirm
target
realli
cypa
still
need
